The European glaucoma prevention study design and baseline description of the participants.
about
Medical interventions for primary open angle glaucoma and ocular hypertensionDiagnostic tools for glaucoma detection and management.Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial.Clinical options for the reduction of elevated intraocular pressureThe Heidelberg retina tomograph ancillary study to the European glaucoma prevention study: study design and baseline factors.Advanced imaging for glaucoma study: design, baseline characteristics, and inter-site comparison.The accuracy and clinical application of predictive models for primary open-angle glaucoma in ocular hypertensive individuals.The rate of visual field change in the ocular hypertension treatment study.Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertensionSeries length used during trend analysis affects sensitivity to changes in progression rate in the ocular hypertension treatment studySymmetry between the right and left eyes of the normal retinal nerve fiber layer measured with optical coherence tomography (an AOS thesis).Specification of progression in glaucomatous visual field loss, applying locally condensed stimulus arrangementsPerimetry, tonometry and epidemiology: the fate of glaucoma management.The value of visual field testing in the era of advanced imaging: clinical and psychophysical perspectives.Treatment of raised intraocular pressure and prevention of glaucoma.The times they are a-changin': time to change glaucoma management.[Differentiation of ocular hypertension].
P2860
Q24243220-5B0D7FC8-7287-4891-89C6-05E3E85A4AC5Q33387777-817072ED-8BEC-4B2B-80FB-4309642BFFC5Q33541683-AD88D263-8C2A-4DB4-812E-D77A3B75A582Q34708267-A56E6BB3-CE10-4B2A-A711-536C3F00A9E0Q34741660-4311E242-E947-4F95-AD03-BBE4010013A3Q34778806-242F5530-3A1E-4D30-A983-CA8D28B71E29Q35052597-664B80C3-FB17-4EDE-80E8-83B7B5A6ECE1Q35797177-DE19FAB6-6A82-4B78-BA3A-0860CCA68E21Q36016893-0506A18D-2B62-4D7A-8623-0A8F65646A73Q36683623-68CDA713-7B07-45CE-A94E-02067F63D17DQ37106347-4795BF5D-5EC0-4D5A-AD2E-E5BB023CCA31Q37418665-56906B53-A9AA-4E30-85D6-06080A9F8A3EQ37880251-5BC64FDF-9C53-4E38-956B-06BAAACD55A3Q39391365-0E7D3D53-E9F7-420A-99AE-C0C975D5D687Q42782384-6BF43701-45E9-4E61-BC95-3DA749ED9478Q43544157-13291E8E-9929-4E94-8FE1-1F88B5FE1664Q53067734-6255EF30-BE59-4E5E-A866-1D010AAC9212
P2860
The European glaucoma prevention study design and baseline description of the participants.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
The European glaucoma preventi ...... scription of the participants.
@en
The European glaucoma preventi ...... scription of the participants.
@nl
type
label
The European glaucoma preventi ...... scription of the participants.
@en
The European glaucoma preventi ...... scription of the participants.
@nl
prefLabel
The European glaucoma preventi ...... scription of the participants.
@en
The European glaucoma preventi ...... scription of the participants.
@nl
P2093
P1433
P1476
The European glaucoma preventi ...... scription of the participants.
@en
P2093
European Glaucoma Prevention Study Group
Ingrid Adamsons
Norbert Pfeiffer
Stefano Miglior
Thierry Zeyen
Valter Torri
P304
P356
10.1016/S0161-6420(02)01167-3
P577
2002-09-01T00:00:00Z